169 related articles for article (PubMed ID: 37246885)
1. Glioma Metabolic Feedback In Situ: A First-In-Human Pharmacodynamic Trial of Difluoromethylornithine + AMXT-1501 Through High-Molecular Weight Microdialysis.
Riviere-Cazaux C; Neth BJ; Hoplin MD; Wessel B; Miska J; Kizilbash SH; Burns TC
Neurosurgery; 2023 Oct; 93(4):932-938. PubMed ID: 37246885
[TBL] [Abstract][Full Text] [Related]
2. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
3. Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci.
Ayoola MB; Shack LA; Lee JH; Lim J; Eoh H; Swiatlo E; Phanstiel O; Nanduri B
Sci Rep; 2022 Jul; 12(1):11804. PubMed ID: 35821246
[TBL] [Abstract][Full Text] [Related]
4. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Saulnier Sholler GL; Gerner EW; Bergendahl G; MacArthur RB; VanderWerff A; Ashikaga T; Bond JP; Ferguson W; Roberts W; Wada RK; Eslin D; Kraveka JM; Kaplan J; Mitchell D; Parikh NS; Neville K; Sender L; Higgins T; Kawakita M; Hiramatsu K; Moriya SS; Bachmann AS
PLoS One; 2015; 10(5):e0127246. PubMed ID: 26018967
[TBL] [Abstract][Full Text] [Related]
5. Polyamines as biomarkers of cervical intraepithelial neoplasia.
Nishioka K; Melgarejo AB; Lyon RR; Mitchell MF
J Cell Biochem Suppl; 1995; 23():87-95. PubMed ID: 8747382
[TBL] [Abstract][Full Text] [Related]
6. Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.
Khan A; Gamble LD; Upton DH; Ung C; Yu DMT; Ehteda A; Pandher R; Mayoh C; Hébert S; Jabado N; Kleinman CL; Burns MR; Norris MD; Haber M; Tsoli M; Ziegler DS
Nat Commun; 2021 Feb; 12(1):971. PubMed ID: 33579942
[TBL] [Abstract][Full Text] [Related]
7. Impact of Difluoromethylornithine and AMXT 1501 on Gene Expression and Capsule Regulation in
Ayoola MB; Shack LA; Phanstiel O; Nanduri B
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397415
[No Abstract] [Full Text] [Related]
8. The effects of DFMO on polyamine metabolism in the inner ear.
Marks SC; Mattox DE; Casero RA
Hear Res; 1991 Jun; 53(2):230-6. PubMed ID: 1880077
[TBL] [Abstract][Full Text] [Related]
9. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
Merali S; Clarkson AB
Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1,N8-bis(ethyl)spermidine.
Casero RA; Go B; Theiss HW; Smith J; Baylin SB; Luk GD
Cancer Res; 1987 Aug; 47(15):3964-7. PubMed ID: 3038303
[TBL] [Abstract][Full Text] [Related]
11. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine.
Pfaller MA; Riley J; Gerarden T
J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402
[TBL] [Abstract][Full Text] [Related]
12. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
13. Polyamine depletion and growth inhibition of Cryptococcus neoformans by alpha-difluoromethylornithine and cyclohexylamine.
Pfaller MA; Riley J; Gerarden T
Mycopathologia; 1990 Oct; 112(1):27-32. PubMed ID: 2250691
[TBL] [Abstract][Full Text] [Related]
14. Biochemical changes associated with alpha-difluoromethylornithine uptake and resistance in Trypanosoma brucei.
Bellofatto V; Fairlamb AH; Henderson GB; Cross GA
Mol Biochem Parasitol; 1987 Oct; 25(3):227-38. PubMed ID: 3122042
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO).
Kadmon D
J Cell Biochem Suppl; 1992; 16H():122-7. PubMed ID: 1289667
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine.
Gerner EW; Garewal HS; Emerson SS; Sampliner RE
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):325-30. PubMed ID: 8061581
[TBL] [Abstract][Full Text] [Related]
17. Effects of gestational or neonatal treatment with alpha-difluoromethylornithine on ornithine decarboxylase and polyamines in developing rat brain and on adult rat neurochemistry.
Sparapani M; Virgili M; Caprini M; Facchinetti F; Ciani E; Contestabile A
Exp Brain Res; 1996 Mar; 108(3):433-40. PubMed ID: 8801123
[TBL] [Abstract][Full Text] [Related]
18. Differential sensitivity of various human tumors to inhibition of polyamine biosynthesis in vivo.
Saydjari R; Alexander RW; Upp JR; Barranco SC; Townsend CM; Thompson JC
Int J Cancer; 1991 Jan; 47(1):44-8. PubMed ID: 1985877
[TBL] [Abstract][Full Text] [Related]
19. Characterising the Response of Human Breast Cancer Cells to Polyamine Modulation.
Akinyele O; Wallace HM
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067619
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
